Xeomin vs Botox for Treatment of Overactive Bladder Syndrome

Clinical trial NCT06034288 · UNKNOWN

Trial details

NCT number: NCT06034288
Sponsor: Walter Reed National Military Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Overactive Bladder Syndrome

Start date: 2023-05-04
Primary completion: 2024-06-30
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.